Annual Retained Earnings
-$304.95 M
+$49.27 M+13.91%
December 31, 2023
Summary
- As of February 7, 2025, AMLX annual retained earnings is -$304.95 million, with the most recent change of +$49.27 million (+13.91%) on December 31, 2023.
- During the last 3 years, AMLX annual retained earnings has fallen by -$237.03 million (-349.02%).
- AMLX annual retained earnings is now -1089.63% below its all-time high of -$25.63 million, reached on December 31, 2019.
Performance
AMLX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$569.15 M
-$72.70 M-14.65%
September 30, 2024
Summary
- As of February 7, 2025, AMLX quarterly retained earnings is -$569.15 million, with the most recent change of -$72.70 million (-14.65%) on September 30, 2024.
- Over the past year, AMLX quarterly retained earnings has dropped by -$259.47 million (-83.79%).
- AMLX quarterly retained earnings is now -738.04% below its all-time high of -$67.91 million, reached on December 31, 2020.
Performance
AMLX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
AMLX Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +13.9% | -83.8% |
| 3 y3 years | -349.0% | -83.8% |
| 5 y5 years | -1089.6% | -83.8% |
AMLX Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -95.7% | +13.9% | -265.2% | at low |
| 5 y | 5-year | -1089.6% | +13.9% | -738.0% | at low |
| alltime | all time | -1089.6% | +13.9% | -738.0% | at low |
Amylyx Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$569.15 M(+14.6%) |
| Jun 2024 | - | -$496.44 M(+17.2%) |
| Mar 2024 | - | -$423.74 M(+39.0%) |
| Dec 2023 | -$304.95 M(-13.9%) | -$304.95 M(-1.5%) |
| Sep 2023 | - | -$309.68 M(-6.3%) |
| Jun 2023 | - | -$330.57 M(-6.3%) |
| Mar 2023 | - | -$352.65 M(-0.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | -$354.22 M(+127.3%) | -$354.22 M(+13.7%) |
| Sep 2022 | - | -$311.52 M(+20.9%) |
| Jun 2022 | - | -$257.76 M(+26.5%) |
| Mar 2022 | - | -$203.69 M(+30.7%) |
| Dec 2021 | -$155.84 M(+129.5%) | -$155.84 M(+22.2%) |
| Sep 2021 | - | -$127.50 M(+87.7%) |
| Dec 2020 | -$67.91 M(+164.9%) | -$67.91 M |
| Dec 2019 | -$25.63 M | - |
FAQ
- What is Amylyx Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Amylyx Pharmaceuticals?
- What is Amylyx Pharmaceuticals annual retained earnings year-on-year change?
- What is Amylyx Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Amylyx Pharmaceuticals?
- What is Amylyx Pharmaceuticals quarterly retained earnings year-on-year change?
What is Amylyx Pharmaceuticals annual retained earnings?
The current annual retained earnings of AMLX is -$304.95 M
What is the all time high annual retained earnings for Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals all-time high annual retained earnings is -$25.63 M
What is Amylyx Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, AMLX annual retained earnings has changed by +$49.27 M (+13.91%)
What is Amylyx Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of AMLX is -$569.15 M
What is the all time high quarterly retained earnings for Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals all-time high quarterly retained earnings is -$67.91 M
What is Amylyx Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, AMLX quarterly retained earnings has changed by -$259.47 M (-83.79%)